Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Heidelberg
Clinical trial register · Germany

Clinical Trials in Heidelberg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5087 matching records held by the registry are in this view. Synced 20 Nov 2026, 03:18 UTC
5087
Studies in scope
all four open statuses
2894
Recruiting now
open to new participants
991
Lead sponsors
across recruiting studies
Top sites
Münster 2 Höchheim 2 Bochum 1 Marburg 1 München 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital Heidelberg50 AstraZeneca29 Janssen Research & Development, LLC27 Merck Sharp & Dohme LLC19 Novartis Pharmaceuticals17 AbbVie15 Hoffmann-La Roche15 Heidelberg University13 Amgen12 German Cancer Research Center11 Bristol-Myers Squibb11 Boehringer Ingelheim10 Eli Lilly and Company9 University Hospital Tuebingen7 Celgene7 Pfizer6 Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest6 Technische Universität Dresden6 Bayer6 European Organisation for Research and Treatment of Cancer - EORTC6 Daiichi Sankyo5 Nationwide Children's Hospital5 University Hospital, Basel, Switzerland4 Jasper Gerritsen4 W.L.Gore & Associates4 Jena University Hospital4 Alnylam Pharmaceuticals4 Philogen S.p.A.4 Biogen4 Novo Nordisk A/S4 Alexion Pharmaceuticals, Inc.4 Sanofi4 Genentech, Inc.3 Revolution Medicines, Inc.3 Immunocore Ltd3 Edwards Lifesciences3 Takeda3 Juergen Debus3 Genmab3 BioNTech SE3 University of Leipzig3 GlaxoSmithKline3 Hannover Medical School3 Cytokinetics3 CatalYm GmbH2 Exelixis2 Replimune, Inc.2 Marc Bosiers, MD2 AO Innovation Translation Center2 Gilead Sciences2 Institut de Recherches Internationales Servier2 NEC Bio B.V2 Intuitive Surgical2 Cullinan Therapeutics Inc.2 Universitätsklinikum Hamburg-Eppendorf2 VectivBio AG2 OncoHost Ltd.2 Bluefin Biomedicine, Inc.2 University of Heidelberg Medical Center2 iOMEDICO AG2 Seagen, a wholly owned subsidiary of Pfizer2 University of Zurich2 NovaGo Therapeutics AG2 Dicerna Pharmaceuticals, Inc., a Novo Nordisk company2 University Medical Center Groningen2 Jazz Pharmaceuticals2 BeOne Medicines2 Joseph Broderick, MD2 Charite University, Berlin, Germany2 Abivax S.A.2 Apogee Therapeutics, Inc.2 European Myeloma Network B.V.2 University Hospital, Essen2 Ipsen2 BioInvent International AB2 Leiden University Medical Center2 Insmed Incorporated2 Erasmus Medical Center2 Immatics Biotechnologies GmbH2 Deciphera Pharmaceuticals, LLC1 BioCryst Pharmaceuticals1 PharmaMar1 Istituto Giannina Gaslini1 Immatics US, Inc.1 Abiomed Inc.1 Dr. Gerhard Mann chem.-pharm. Fabrik GmbH1 Mario Negri Institute for Pharmacological Research1 Summit Therapeutics1 C. R. Bard1 Reprieve Cardiovascular, Inc1 Pulmonx Corporation1 Abbott Medical Devices1 Janssen-Cilag Ltd.1 Prof. Dr. Richard F Schlenk1 University of Regensburg1 EMD Serono Research & Development Institute, Inc.1 Queen Silvia Children's Hospital, Gothenburg, Sweden1 Uptake Medical Technology, Inc.1 Regeneron Pharmaceuticals1 Acerta Pharma BV1 UroTrials Company (GmbH)1 University Hospital Schleswig-Holstein1 Medical University of Graz1 University of Oldenburg1 Pierre Fabre Medicament1 Morair Medtech, LLC1 Heinrich-Heine University, Duesseldorf1 Genetix Biotherapeutics Inc.1 Avidity Biosciences, Inc.1 M.A. Med Alliance S.A.1 Zimmer, GmbH1 University of Cologne1 University Hospital Goettingen1 CSL Behring1 Shape Memory Medical, Inc.1 CytoSorbents, Inc1 Alfasigma S.p.A.1 IO Biotech1 Savara Inc.1 Tesaro, Inc.1 Janssen Pharmaceutica N.V., Belgium1 Carl Zeiss Meditec AG1 Syndax Pharmaceuticals1 Imbria Pharmaceuticals, Inc.1 European Foundation for Study of Chronic Liver Failure1 University of Virginia1 Yale University1 Ultragenyx Pharmaceutical Inc1 NovoCure GmbH1 Lea Kölsch1 VisDura, Inc.1 JOTEC GmbH1 Société des Produits Nestlé (SPN)1 Insel Gruppe AG, University Hospital Bern1 Avalyn Pharma Inc.1 Janssen Biotech, Inc.1 Boston Scientific Corporation1 Philipp Dutkowski1 Intellia Therapeutics1 Arcus Biosciences, Inc.1 Neurimmune AG1 IDEAYA Biosciences1 Turning Point Therapeutics, Inc.1 DePuy International1 Occlutech International AB1 Heidelberg Pharma AG1 HUYABIO International, LLC.1 Kite, A Gilead Company1 Deniz Göcebe1 Neurocrine Switzerland GmbH1 RWTH Aachen University1 Actelion1 Neuravi Limited1 Smith & Nephew, Inc.1 University of California, San Francisco1 Oruka Therapeutics, Inc.1 German CLL Study Group1 AskBio Inc1 Insight Molecular Diagnostics1 Annetine Gelijns1 German Federal Institute for Risk Assessment1 NYU Langone Health1 Boston Children's Hospital1 Fundacao Champalimaud1 Akcea Therapeutics1 Inhibrx Biosciences, Inc1 Celldex Therapeutics1 Universität Münster1 Astellas Pharma Global Development, Inc.1 TransThera Sciences (Nanjing), Inc.1 AtriCure, Inc.1 Medtronic Cardiovascular1 Vir Biotechnology, Inc.1 Alliance for Clinical Trials in Oncology1 Kartos Therapeutics, Inc.1 Johann Wolfgang Goethe University Hospital1 MedSIR1 Prof. Dr. Paul Brinkkoetter1 MicroPort CRM1 Hidde van der Ploeg1 Phenox GmbH1 TORL Biotherapeutics, LLC1 Eidos Therapeutics, a BridgeBio company1 Central Institute of Mental Health, Mannheim1 iSTAR Medical1 Miltenyi Biomedicine GmbH1 Zura Bio Inc1 TolerogenixX GmbH1 Aragon Pharmaceuticals, Inc.1 Ionis Pharmaceuticals, Inc.1 Dr. Rebecca Schule1 University of Hohenheim1 Pamgene International B.V.1 Michael Dill1 Esteve Pharmaceuticals, S.A.1 Baxalta now part of Shire1 Italian Sarcoma Group1 G&G Biotechnology Ltd.1 Prof. Dr. Thomas Luft1 Inmunova S.A.1 Agios Pharmaceuticals, Inc.1 ThermoMind Ltd.1 HighLife SAS1 Das Radiologische Zentrum1 Indiana University1 Incyte Corporation1 neurescue1 Day One Biopharmaceuticals, Inc.1 Nova Laboratories Limited1 Basilea Pharmaceutica1 Stoke Therapeutics, Inc1 Calico Life Sciences LLC1 Svenja Taubner1 Pulmovant, Inc.1 Global Coalition for Adaptive Research1 Elios Vision, Inc.1 Icahn School of Medicine at Mount Sinai1 Forma Therapeutics, Inc.1 Medtronic Cardiac Ablation Solutions1 Institut National de la Santé Et de la Recherche Médicale, France1 pharmaand GmbH1 Deutsches Herzzentrum Muenchen1 Travere Therapeutics, Inc.1 Amicus Therapeutics1 Profound Medical Inc.1 Anocca AB1 Inari Medical1 Taiho Oncology, Inc.1 Rigel Pharmaceuticals1 Galecto Biotech AB1 Gossamer Bio USA, Inc.1 Airway Therapeutics, Inc.1 Rein Therapeutics1 Fondazione IRCCS Policlinico San Matteo di Pavia1 Cardionovum GmbH1 Dizal Pharmaceuticals1 BioNTech Cell & Gene Therapies GmbH1 Vall d'Hebron Institute of Oncology1 IHF GmbH - Institut für Herzinfarktforschung1 Immunovant Sciences GmbH1 Pulmair Medical, Inc.1 OSE Immunotherapeutics1 Ceretrieve Ltd.1 Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 Valo Therapeutics Oy1 Shenzhen Core Medical Technology CO.,LTD.1 Partner Therapeutics, Inc.1 Nuvalent Inc.1 PMV Pharmaceuticals, Inc1 Fore Biotherapeutics1 Oncolytics Biotech1 Loxo Oncology, Inc.1 MED-EL Elektromedizinische Geräte GmbH1 Ivy Brain Tumor Center1 Annexon, Inc.1 United Therapeutics1 Camurus AB1 Apreo Health, Inc.1 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1 Medical University of Vienna1 Neurocrine Biosciences1 Vicore Pharma AB1 Sigmund Freud PrivatUniversitat1 Nuvaira, Inc.1 University of Utah1 Clear sponsor filter
Target enrolment
to

Trials with a site in Heidelberg

1 of 5087 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
Amicus Therapeutics
Phase 3
36
Giessen, Heidelberg, Höchheim, Münster
2023-07-18
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 November 2026. https://priyalifescience.com/clinical-trials-germany/city/heidelberg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,087 studies in total at the last sync on 20 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Heidelberg that also match the filters currently applied.

How many clinical trials are recruiting in Heidelberg?

1 of the 1 studies on this page are recruiting new participants as of the 20 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Heidelberg), 1 studies
PhaseStudiesRecruitingShare
Phase 311100%

Most active sponsors

Lead sponsors with the most studies (Heidelberg)
Lead sponsorStudiesRecruiting
Amicus Therapeutics11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.